Catechol-binding serines of β2-adrenergic receptors control the equilibrium between active and inactive receptor states

被引:0
|
作者
Ambrosio, C
Molinari, P
Cotecchia, S
Costa, T
机构
[1] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy
[2] Univ Lausanne, Fac Med, Inst Pharmacol & Toxicol, Lausanne, Switzerland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The binding free energy for the interaction between serines 204 and 207 of the fifth transmembrane helix of the beta(2)-adrenergic receptor (beta(2)-AR) and catecholic hydroxyl (OH) groups of adrenergic agonists was analyzed using double mutant cycles. Binding affinities for catecholic and noncatecholic agonists were measured in wild-type and mutant receptors, carrying alanine replacement of the two serines (S204A, S207A beta(2)-AR), a constitutive activating mutation, or both. The free energy coupling between the losses of binding energy attributable to OH deletion from the ligand and from the receptor indicates a strong interaction (nonadditivity) as expected for a direct binding between the two sets of groups. However, we also measured a significant interaction between the deletion of OH groups from the receptor and the constitutive activating mutation. This suggests that a fraction of the decrease in agonist affinity caused by serine mutagenesis may involve a shift in the conformational equilibrium of the receptor toward the inactive state. Direct measurements using a transient transfection assay confirm this prediction. The constitutive activity of the (S204A, S207A) beta(2)-AR mutant is 50 to 60% lower than that of the wild-type beta(2)-AR. We conclude that S204 and S207 do not only provide a docking site for the agonist, but also control the equilibrium of the receptor between active (R*) and inactive (R) forms.
引用
收藏
页码:198 / 210
页数:13
相关论文
共 20 条
  • [1] Allosteric effect of nanobody binding on ligand-specific active states of the β2-adrenergic receptor
    Chen, Yue
    Fleetwood, Oliver
    Conesa, Sergio Perez
    Delemotte, Lucie
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 53 - 53
  • [2] β-arrestin binding to β2-adrenergic receptors requires both agonist occupancy and receptor phosphorylation
    Krasel, C
    Bünemann, M
    Lorenz, K
    Lohse, MJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R18 - R18
  • [3] Distinctive communication networks in inactive states of β2-adrenergic receptor: Mutual information and entropy transfer analysis
    Sogunmez, Nuray
    Akten, Ebru Demet
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2020, 88 (11) : 1458 - 1471
  • [4] Intrinsic Dynamics and Causality in Correlated Motions Unraveled in Two Distinct Inactive States of Human β2-Adrenergic Receptor
    Sogunmez, Nuray
    Akten, E. Demet
    JOURNAL OF PHYSICAL CHEMISTRY B, 2019, 123 (17): : 3630 - 3642
  • [5] Targeting β-adrenergic receptor subtypes to caveolae:: Differences between endogenous and heterologously expressed β1- but not β2-adrenergic receptors
    Shor, J
    Curran, PK
    Fishman, PH
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 81A - 82A
  • [6] CH/π hydrogen bonds play a role in ligand recognition and equilibrium between active and inactive states of the β2 adrenergic receptor: An ab initio fragment molecular orbital (FMO) study
    Ozawa, Tomonaga
    Okazaki, Kosuke
    Kitaura, Kazuo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (17) : 5231 - 5237
  • [7] Cross talk between m3-muscarinic and β2-adrenergic receptors at the level of receptor phosphorylation and desensitization
    Budd, DC
    Challiss, RAJ
    Young, KW
    Tobin, AB
    MOLECULAR PHARMACOLOGY, 1999, 56 (04) : 813 - 823
  • [8] The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
    Daisuke Fujinami
    Abdullah-Al -Mahin
    Khaled M. Elsayed
    Mohammad R. Islam
    Jun-ichi Nagao
    Urmi Roy
    Sabrina Momin
    Takeshi Zendo
    Daisuke Kohda
    Kenji Sonomoto
    Communications Biology, 1
  • [9] The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
    Fujinami, Daisuke
    Abdullah-Al-Mahin
    Elsayed, Khaled M.
    Islam, Mohammad R.
    Nagao, Jun-ichi
    Roy, Urmi
    Momin, Sabrina
    Zendo, Takeshi
    Kohda, Daisuke
    Sonomoto, Kenji
    COMMUNICATIONS BIOLOGY, 2018, 1
  • [10] Optical control of the β2-adrenergic receptor with opto-prop-2: A cis-active azobenzene analog of propranolol
    Bosma, Reggie
    Dijon, Nicola C.
    Zheng, Yang
    Schihada, Hannes
    Hauwert, Niels J.
    Shi, Shuang
    Arimont, Marta
    Riemens, Rick
    Custers, Hans
    van de Stolpe, Andrea
    Vischer, Henry F.
    Wijtmans, Maikel
    Holliday, Nicholas D.
    Kuster, Diederik W. D.
    Leurs, Rob
    ISCIENCE, 2022, 25 (09)